Levofloxacin Hemihydrate
Cat.No:IL0090 Solarbio
CAS:138199-71-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Anti-Infection >
Anti-Bacterial >
Levofloxacin HemihydrateCAS:138199-71-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 138199-71-0 |
Name | Levofloxacin Hemihydrate |
Molecular Formula | C18H20FN3O4·1/2H2O |
Molecular Weight | 370.38 |
Solubility | Soluble in Water/DMSO ≥5mg/mL |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 604-067-2 |
MDL | MFCD07772024 |
SMILES | O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[0.5H2O] |
InChIKey | SUIQUYDRLGGZOL-RCWTXCDDSA-N |
InChI | InChI=1S/2C18H20FN3O4.H2O/c2*1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h2*7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H2/t2*10-;/m00./s1 |
PubChem CID | 3033924 |
Target Point | Bacterial;Topoisomerase |
Passage | DNA Damage/DNA Repair;Anti-infection |
Background | Levofloxacin Hemihydrate is an antibiotic compound that inhibits bacterial DNA gyrase activity. |
Unit | Bottle |
Specification | 50mg 10mM*1mL in DMSO 100mg |
是抗生素化合物,抑制细菌DNA旋转酶活性。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
The Mycobacterium tuberculosis CRISPR-Associated Cas3 Involves Persistence and Tolerance to Anti-Tubercular Drugs
Click to check >>Author:Wei J, Lu N, Li Z, Wu X, Jiang T, Xu L, Yang C, Gu
IF:3.0470
Publish_to:Biomed Res Int.
PMID:31061828